• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.53% Nasdaq Up 0.11%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    48.44 Up 0.12(0.25%) Jul 7, 4:00PM EDT
    Add to Portfolio
    Prev Close:48.32
    Open:48.56
    Bid:47.09 x 100
    Ask:N/A
    1y Target Est:56.25
    Beta:-1.77
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:47.07 - 48.99
    52wk Range:12.63 - 49.49
    Volume:632,726
    Avg Vol (3m):918,668
    Market Cap:4.14B
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 0.25%4.14B
    ABTUp 0.94%74.75B
    LLYUp 2.76%93.97B
    PFEUp 1.44%207.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):208.78
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-0.86
    Quarterly EPS Est (Jun-15) :-0.29
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):5.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback